


Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
DOSTINEX is a prescription medication containing the active ingredient cabergoline, which is classified as an ergot-derived dopamine receptor agonist.
DOSTINEX (cabergoline) tablets are indicated for the treatment of hyperprolactinemic disorders in adults. It functions as a dopamine D2 receptor agonist, effectively lowering serum prolactin levels. The tablet formulation is designed for oral administration and is available in a single strength of 0.5 mg. It is contraindicated in patients with certain cardiovascular or fibrotic histories and requires specific monitoring during treatment.
Treatment of hyperprolactinemic disorders, whether idiopathic or due to pituitary adenomas, in adult patients.
Not indicated for inhibition or suppression of physiologic postpartum lactation.
Initiate with 0.25 mg orally twice weekly.
Titrate incrementally by 0.25 mg twice weekly at intervals no less than 4 weeks to achieve normal serum prolactin levels.
Maximum recommended dose: 1 mg twice weekly.
Administer with or without food.
Evaluate cardiac valvular status via echocardiogram prior to initiation.
